CAMP4 Therapeutics

CAMP4 Therapeutics is a clinical-stage RNA-medicines biotechnology company based in Cambridge, Massachusetts, pioneering a new class of antisense oligonucleotide (ASO) therapeutics designed to increase targeted gene expression. Built on the company's RAP Platform (Regulatory RNA Activating Platform), which combines epigenomics, computational biology, and machine learning to map the regulatory RNA and signaling circuits controlling gene expression, CAMP4 develops first-in-class medicines for diseases caused by insufficient protein expression, with an initial focus on central nervous system and metabolic disorders such as urea cycle disorders and SYNGAP1. Founded by CEO Josh Mandel-Brehm with scientific co-founders Rick Young (Whitehead Institute/MIT) and Len Zon (Boston Children's Hospital/Harvard), CAMP4 is backed by Andreessen Horowitz (a16z). This is a corporate/therapeutics company profile in the API Evangelist network; CAMP4 publishes no public developer API, OpenAPI, or developer portal, so no API artifacts apply.

CAMP4 Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, RNA Medicines, Antisense Oligonucleotide, and Gene Expression.

CAMP4 Therapeutics’ developer surface includes engineering blog, support, signup flow, and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub

9.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyRNA MedicinesAntisense OligonucleotideGene ExpressionDrug DiscoveryTherapeuticsLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 9.1/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 2.6 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/camp4: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Get Started 1

Portal, sign-up, and the first successful call

SignUp

SignUp

Operate 1

Status, limits, changes, and where to get help

Support

Support

Company 4

The organization behind the API

Website

Website

About

About

Blog

Blog

LinkedIn

Source (apis.yml)

aid: camp4
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/camp4.png
name: CAMP4 Therapeutics
description: CAMP4 Therapeutics is a clinical-stage RNA-medicines biotechnology company based in Cambridge, Massachusetts,
  pioneering a new class of antisense oligonucleotide (ASO) therapeutics designed to increase targeted gene expression. Built
  on the company's RAP Platform (Regulatory RNA Activating Platform), which combines epigenomics, computational biology, and
  machine learning to map the regulatory RNA and signaling circuits controlling gene expression, CAMP4 develops first-in-class
  medicines for diseases caused by insufficient protein expression, with an initial focus on central nervous system and metabolic
  disorders such as urea cycle disorders and SYNGAP1. Founded by CEO Josh Mandel-Brehm with scientific co-founders Rick Young
  (Whitehead Institute/MIT) and Len Zon (Boston Children's Hospital/Harvard), CAMP4 is backed by Andreessen Horowitz (a16z).
  This is a corporate/therapeutics company profile in the API Evangelist network; CAMP4 publishes no public developer API,
  OpenAPI, or developer portal, so no API artifacts apply.
url: https://raw.githubusercontent.com/api-evangelist/camp4/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
x-tier: stub
x-tier-reason: portfolio-lead
x-industry: biotechnology
x-api-surface: none
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- RNA Medicines
- Antisense Oligonucleotide
- Gene Expression
- Drug Discovery
- Therapeutics
- Life Sciences
apis: []
common:
- type: Website
  url: https://www.camp4tx.com/
- type: About
  url: https://www.camp4tx.com/about/
- type: Blog
  url: https://www.camp4tx.com/category/in-the-news/
- type: Support
  url: https://www.camp4tx.com/contact/
- type: SignUp
  url: https://www.camp4tx.com/about/join-camp4/
- type: LinkedIn
  url: https://www.linkedin.com/company/camp4-therapeutics
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence